Market Overview

Benzinga's Top Pre-Market Gainers

Related LXRX
Lexicon Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual Symposium
US Stock Futures Rise Ahead Of Housing, Consumer Confidence Data
Related ARIA
Benzinga's Top #PreMarket Losers
Mid-Morning Market Update: Markets Open Lower; BlackBerry To Acquire Good Technology For $425M

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 10.70% to $2.07 in the pre-market session. Lexicon Pharmaceuticals reported that it has received "Fast Track" status from the FDA for the development of LX1033.

Ariad Pharmaceuticals (NASDAQ: ARIA) added 3.48% to $19.59 in the pre-market session. ARIAD Pharmaceuticals reported that the FDA has granted accelerated approval of Iclusig™ (ponatinib).

American Capital Agency (NASDAQ: AGNC) moved up 2.85% to $31.06 in the pre-market session. American Capital Agency declared a Q4 cash dividend of $1.25 per common share.

Sprint Nextel (NYSE: S) soared 2.16% to $5.67 in the pre-market trading. Sprint will acquire the approximately 50% stake in Clearwire (NASDAQ: CLWR) it does not currently own for $2.97 per share.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (AGNC + ARIA)

View Comments and Join the Discussion!

Get Benzinga's Newsletters